Concepedia

Author

Lu Cao

Tianjin Medical University Cancer Institute and HospitalORCID

Also Known As

Cao Lu, Cao, Lu, Lu Cao

19

Publications

484

Citations

12

H-Index

25

Concepts

All Affiliations

Tianjin Medical University Cancer Institute and HospitalTianjin Medical UniversityTianjin People's HospitalTianjin Medical University General Hospital
LC

About

Lu Cao is an author at Tianjin Medical University Cancer Institute and Hospital specializing in medicine, tumor biology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

183

2

Cell Biology

3

3

124

3

Pathology

3

3

107

4

Immunology

2

2

81

5

Cellular Physiology

1

1

50

Lu Cao

×

12

Publications

392

Citations

11

H-Index

YearCitations

FGF4 induces epithelial-mesenchymal transition by inducing store-operated calcium entry in lung adenocarcinoma

Lisha Qi, Wangzhao Song, Lingmei Li,

Oncotarget

2016

50

Human nonsense-mediated RNA decay regulates EMT by targeting the TGF-ß signaling pathway in lung adenocarcinoma

Lu Cao, Lisha Qi, Lin Zhang,

Cancer Letters

2017

49

Androgen receptor and heat shock protein 27 co-regulate the malignant potential of molecular apocrine breast cancer

Xiaozhen Liu, Changyun Feng, Junjun Liu,

Journal of Experimental & Clinical Cancer Research

2018

45

TGF-β1 stimulates epithelial–mesenchymal transition and cancer-associated myoepithelial cell during the progression from in situ to invasive breast cancer

Li Wang, Cong Xu, Xia Liu,

Cancer Cell International

2019

39

ISG15 induces ESRP1 to inhibit lung adenocarcinoma progression

Tongyuan Qu, Wenshuai Zhang, Lisha Qi,

Cell Death and Disease

2020

39

ISG15 targets glycosylated PD-L1 and promotes its degradation to enhance antitumor immune effects in lung adenocarcinoma

Tongyuan Qu, Wenshuai Zhang, Chenhui Yan,

Journal of Translational Medicine

2023

34

The immunohistochemical expression and potential prognostic value of HDAC6 and AR in invasive breast cancer

Congying Li, Lu Cao, Cong Xu,

Human Pathology

2017

32

A high AR:ERα or PDEF:ERα ratio predicts a sub-optimal response to tamoxifen therapy in ERα-positive breast cancer

Lu Cao, Guomin Xiang, Fang Liu,

Cancer Chemotherapy and Pharmacology

2019

27

Epithelial Splicing Regulatory Protein 1 Inhibits the Invasion and Metastasis of Lung Adenocarcinoma

Lingmei Li, Lisha Qi, Tongyuan Qu,

American Journal Of Pathology

2018

25

AR–PDEF pathway promotes tumour proliferation and upregulates MYC-mediated gene transcription by promoting MAD1 degradation in ER-negative breast cancer

Lu Cao, Cong Xu, Guomin Xiang,

Molecular Cancer

2018

25

Page 1